(December 17, 2018, 11:22 AM EST) -- WASHINGTON, D.C. — A federal judicial panel will hear arguments Jan. 31 on whether to consolidate 11 federal valsartan lawsuits in a multidistrict litigation and, if so, whether the MDL should be limited to alleged economic injuries or include personal injury claims (In Re: Valsartan NDMA Contamination Litigation, MDL Docket No. 2875, JPMDL)....